Mechanisms by which octreotide ameliorates symptoms in the dumping syndrome

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 3, 1996, Pages 1359-1365

  Hasler, William L ^a   Soudah, Hani C ^a   Owyang, Chung ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; OCTREOTIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MECHANISM; FEMALE; GLUCOSE BLOOD LEVEL; HEMOCONCENTRATION; HEMODYNAMICS; HUMAN; INSULIN BLOOD LEVEL; MALE; POSTGASTRECTOMY SYNDROME; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; SYMPTOMATOLOGY;

ADULT; AGED; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; BLOOD PRESSURE; DOUBLE-BLIND METHOD; DUMPING SYNDROME; FEMALE; HUMANS; INSULIN; MALE; MIDDLE AGED; OCTREOTIDE; TIME FACTORS;

EID: 0030433058     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. BLACKBURN, A. M., CHRISTOPHER, N. D. AND GHATEI, M. A.: Elevation of plasma neurotensin in the dumping syndrome. Clin. Sci. 59: 237-243, 1990.
2. BLOOM, S. R., ROYSTON, C. M. S. AND THOMPSON, J. P. S.: Enteroglucagon release in the dumping syndrome. Lancet 2: 789-791, 1972.
3. BOWER, J. C., PAWLIK, W., FANG, W.-F. AND JACOBSON, E. D.: Pharmacologic effects of gastrointestinal hormones on intestinal oxygen consumption and blood flow. Surgery 78: 515-519, 1975.
4. CHON, C. C., HSIEH, C. P. AND DABNEY, J. M.: Comparison of vascular effects of gastrointestinal hormones on various organs. Am. J. Physiol. 232: H103-H109, 1977.
5. DHARMSATHAPHORN, K., BINDER, H. J. AND DOBBINS, J. W.: Somatostatin stimulates sodium and chloride absorption in the rabbit ileum. Gastroenterology 78: 1559-1565, 1980a.
6. DHARMSATHAPHORN, K., SHERWIN, R. S. AND DOBBINS, J. W.: Somatostatin inhibits fluid secretion in the rat jejunum. Gastroenterology 78: 1554-1558, 1980b.
7. 99mTC-tin in colloid and mouth-to-caecum transit time in man. Digestion 36: 101-107, 1987.
8. GEER, R. J., RICHARDS, W. O., O'DORISIO, T. M., WOLTERING, E. D., WILLIAMS, S., RICE, D. AND ABUMRAD, N. N.: Efficacy of octreotide acetate in the treatment of severe postgastrectomy dumping syndrome. Ann. Surg. 212: 678-687, 1990.
9. GRAY, J. L., DEBAS, H. T. AND MULVAHILL, S. J.: Control of dumping symptoms by somatostatin analogue in patients after gastric surgery. Arch. Surg. 126: 1231-1236, 1991.
10. HAYASHI, M., FLOYD, J. C., PEK, S. AND FAJANS, S. S.: Insulin, proinsulin, glucagon, and gastrin in pancreatic tumors and in plasma of patients with organic hyperinsulinism. J. Clin. Endocrinol. Metab. 44: 681-684, 1977.
11. HOELDTKE, R. D. AND DAVIS, K.: The orthostatic tachycardia syndrome: Evaluation of autonomic function and treatment with octreotide and ergot alkaloids. J. Clin. Endocrinol. Metab. 73: 132-139, 1991.
12. HOPMAN, W. P. M., WOLBERINK, R. G. J., LAMERS, C. B. W. AND VAN TONGEREN, J. H. N.: Treatment of the dumping syndrome with the somatostatin analog SMS 201-995. Ann. Surg. 207: 155-159, 1988.
13. JOHANSSON, C., WISEN, O., EFENDIC, S. AND UVNAS-WALLENSTEN, K.: Effects of somatostatin on gastrointestinal propagation and absorption of oral glucose in man. Digestion 22: 126-137, 1981.
14. KREJS, G. J.: Effect of somatostatin and atropine infusion on intestinal transit time and fructose absorption in the perfused human jejunum. Diabetes 33: 548-551, 1984.
15. LONG, R. G., ADRIAN, T. E. AND BLOOM, S. R.: Somatostatin and the dumping syndrome. Br. Med. J. 290: 886-888, 1985.
16. MACHELLA, T. E.: Mechanism of postgastrectomy "dumping" syndrome. Ann. Surg. 130: 145-159, 1949.
17. MALMUD, L. S., FISHER, R. S., KNIGHT, L. C. AND ROCK, E.: Scintigraphic evaluation of gastric emptying. Semin. Nucl. Med. 12: 116-125, 1982.
18. MATON, P. N., GARDNER, J. D. AND JENSEN, R. T.: Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors. Dig. Dis. Sci. 34 (3 Suppl): 28S-39S, 1989.
19. PARR, N., GRIME, S., JENKINS, S. A., CRITCHLEY, M., BAXTER, J. AND MACKIE, C.: Somatostatin analog (SMS 201-995) inhibits early rapid gastric emptying after truncal vagotomy and drainage (Abstract). Gut 27: A1272-A1273, 1986.
20. PESKIN, G. W. AND MILLER, L. D.: The role of serotonin in the "dumping syndrome." Arch. Surg. 85: 701-704, 1962.
21. PRIMROSE, J. N. AND JOHNSTON, D.: Somatostatin analog SMS 201-995 (octreotide) as a possible solution to the dumping syndrome after gastrectomy or vagotomy. Br. J. Surg. 76: 140-144, 1989.
22. RALPHS, D. N. L., THOMSON, J. P. S., HAYNES, S., LAWSON-SMITH, C., HOBSLEY, M. AND LEQUESNE, L. P.: The relationship between the rate of gastric emptying and the dumping syndrome. Br. J. Surg. 65: 637-641, 1978.
23. RICHARDS, W. O., GEER, R., O'DORISIO, T. M., ROBARTS, T., PARISH, K. L., RICE, D., WOLTERING, G. AND ABUMRAD, N. N.: Octreotide acetate induces fasting small bowel motility in patients with dumping syndrome. J. Surg. Res. 49: 483-487, 1990.
24. ROSENTHAL, J., RAPHS, S., ZOUPAS, C. AND ESCOBAR-JIMENEZ, F.: Inhibition by somatostatin of renin, blood pressure and cardiac and stroke index in essential hypertension. Circ. Res. 43: suppl. 1, 69-76, 1977.
25. SAGOR, G. R., BRYANT, M. G., GHATEI, M. A., KICK, R. M. AND BLOOM, S. R.: Release of vasoactive intestinal peptide in the dumping syndrome. Br. J. Med. 282: 507-510, 1981.
26. SANDRIC, S., SANTARELLI, P., GHIRLANEDA, G., UCCIOLI, L., BELLOCCI, F., FRUSTACI, A., GRECO, A. AND MANZOLI, U.: Electrophysiologic effects of somatostatin in man (Abstract). Circulation 70: suppl. II, 55, 1984.
27. SAWYERS, J. L.: Management of postgastrectomy syndromes. Am. J. Surg. 159: 8-14, 1990.
28. SCHEMANN, M. AND EHRLEIN, H. J.: Effects of neurohormonal agents on jejunal contraction spread and transit in the fed dog. Gastroenterology 90: 1950-1955, 1986.
29. SOUDAH, H. C., HASLER, W, L. AND OWYANG, C.: Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N. Engl. J. Med. 325: 1461-1467, 1991.
30. SOUDAH, H., HASLER, W. L. AND OWYANG, C.: Somatostatin analog improves symptoms of dumping syndrome with prevention of orthostasis and hyperinsulinemia: Lack of effect on hemoconcentration and gastric emptying (Abstract). Regul. Pept. 40: 254, 1992.
31. VINIK, A. I. AND MOATTARI, A. R.: Use of somatostatin analog in management of carcinoid syndrome. Dig. Dis. Sci. 34 (3 Suppl): 14S-27S, 1989.
32. WOODWARD, E. R. AND NEUSTEIN, C. L.: The late postprandial dumping syndrome. In Postgastrectomy Syndromes, ed. by F. L. Bushkin and E. R. Woodward, pp. 28-33, W. B. Saunders, Philadelphia, 1976.
33. ZEITLIN, I. J. AND SMITH, A. N.: 5-Hydroxyindoles and kinins in the carcinoid and dumping syndromes. Lancet 2: 986-991, 1966.